V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280005830 | 280003649 | -1 | null | null | 2017-08-27 | 2017-09-22 | Cisplatin + Docetaxel | N | Y | 280029776 | IVADO |
| 280005831 | 280003649 | 1.83 | 69.3 | Palliative (P) | 2015-05-06 | 2015-05-06 | CRIZOTINIB | Y | N | 280029776 | FCR |
| 280005832 | 280003650 | 1.76 | null | null | null | 2018-04-11 | VIDE | null | null | 280029781 | CISPLATIN + FLUOROURACIL + RT |
| 280005833 | 280003651 | 1.8 | null | Palliative (P) | 2014-12-22 | 2014-12-23 | Cisplatin + Etoposide (3 day) | N | N | 280029782 | CARBO + FLUOROURACIL |
| 280005834 | 280003651 | 1.71 | 61.2 | Palliative (P) | 2015-08-27 | 2015-09-15 | Docetaxel+Gemcitabine (no prior RT) | null | null | 280029782 | DOXORUBICIN + OLARATUMAB |
| 280005835 | 280003651 | null | 42.2 | Curative (C) | 2015-06-14 | 2015-06-16 | DABRAFENIB | 02 | null | 280029782 | CISPLATIN + FLUOROURACIL + RT |
| 280005836 | 280011096 | 1.65 | null | Curative (C) | 2016-12-13 | 2016-12-17 | EW EuroEwing 99 : VIDE | N | null | 280029786 | VIDE |
| 280005837 | 280003652 | 1.77 | 75 | Adjuvant (A) | 2017-09-14 | 2017-09-16 | GemCarbo Days 1+8 | 02 | N | 280029787 | GEMCITABINE |
| 280005838 | 280003652 | 1.73 | 87 | Curative (C) | 2015-05-11 | 2015-07-10 | Cisplatin + Docetaxel | Y | N | 280029787 | DE-ESCALATE TRIAL |
| 280005839 | 280010050 | 1.73 | 101.3 | Palliative (P) | 2017-04-16 | 2017-04-20 | DE-ESCALATE TRIAL | 02 | N | 280029792 | GEMCARBO |
| 280005840 | 280011097 | 1.69 | 49 | Palliative (P) | 2017-12-26 | 2017-12-26 | Liposomal Doxorubicin (Caelyx) | 02 | N | 280029793 | PACLITAXEL |
| 280005841 | 280003653 | 1.98 | null | Curative (C) | 2016-08-12 | 2016-08-12 | CETUXIMAB + CISPLATIN + FU | N | N | 280029794 | CISPLATIN + FLUOROURACIL + RT |
| 280005842 | 280003653 | 1.67 | 73 | Palliative (P) | 2016-03-21 | 2016-03-22 | Oxaliplatin + Modified de Gramont | 02 | N | 280029794 | IFOSFAMIDE |
| 280005843 | 280003653 | null | 91.65 | Adjuvant (A) | 2015-02-20 | 2015-02-20 | Paclitaxel 7 day | 2 | null | 280029794 | VDC |
| 280005844 | 280003654 | null | null | Palliative (P) | 2016-06-07 | 2016-06-25 | Ipilimumab | N | N | 280029797 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 280005845 | 280003654 | 1.63 | null | Palliative (P) | 2013-04-16 | 2013-04-22 | Rituximab | null | null | 280029797 | VIDE |
| 280005846 | 280003655 | 1.59 | 71 | Palliative (P) | 2014-06-13 | 2014-06-13 | CYCLOPHOSPHAMIDE + THALIDOMIDE | Y | Y | 280029804 | CAPECITABINE + CARBOPLATIN |
| 280005847 | 280003655 | 1.69 | 71.8 | Palliative (P) | 2017-08-07 | 2017-08-07 | Gemcitabine weekly | 2 | null | 280029804 | DOXORUBICIN + OLARATUMAB |
| 280005848 | 280003656 | 1.63 | 7.8 | Curative (C) | 2014-11-12 | 2014-11-14 | LANREOTIDE | 02 | N | 280029806 | IFOSFAMIDE |
| 280005849 | 280003656 | 1.79 | 91.4 | Palliative (P) | 2016-01-21 | 2016-02-05 | Docetaxel+Gemcitabine (no prior RT) | N | Y | 280029806 | CETUXIMAB + CISPLATIN + FU |
| 280005850 | 280003656 | 1.8 | null | Palliative (P) | 2013-03-29 | 2013-04-04 | GEDDIS TRIAL | N | N | 280029806 | LIPOSOMAL DOXORUBICIN |
| 280005851 | 280003657 | 1.79 | 84.8 | Palliative (P) | 2016-08-19 | 2016-09-10 | METHOTREXATE | N | N | 280029811 | DOCETAXEL + GEMCITABINE |
| 280005852 | 280003658 | 1.49 | 106 | Adjuvant (A) | 2018-02-20 | 2018-03-05 | CAPECITABINE + TEMOZOLOMIDE | N | N | 280029812 | CISPLATIN + DOXORUBICIN |
| 280005853 | 280003659 | 1.74 | null | Not known (9) | 2017-04-09 | 2017-04-23 | Paclitaxel 80mg/m2 day 1 8 15 | 02 | N | 280029813 | EURO-EWING |
| 280005854 | 280003659 | 1.89 | 62.8 | Not known (9) | 2015-03-21 | 2015-04-10 | TCF | N | N | 280029813 | CTD |
| 280005855 | 280003660 | null | null | null | 2016-04-28 | 2016-04-28 | VAC | null | null | 280029816 | CISPLATIN + FLUOROURACIL + RT |
| 280005856 | 280003661 | 1.86 | 66.2 | Palliative (P) | 2017-10-21 | 2017-10-22 | CARBOPLATIN + GEMCITABINE | N | N | 280029819 | CARBOPLATIN + PEMETREXED |
| 280005857 | 280003661 | 1.69 | 102.5 | Adjuvant (A) | 2017-12-15 | 2017-12-15 | ECX | null | null | 280029819 | DARS TRIAL |
| 280005858 | 280003662 | null | 78.9 | Adjuvant (A) | 2017-06-26 | 2017-07-06 | Cisplatin + Doxorubicin | N | null | 280029824 | ECX |
| 280005859 | 280003663 | 1.8 | 65.9 | Palliative (P) | null | 2017-03-23 | IPILIMUMAB + NIVOLUMAB | N | N | 280029826 | VIDE |
| 280005860 | 280003663 | 1.73 | 82.4 | null | 2014-05-28 | 2014-05-28 | CETUXIMAB + CISPLATIN + FU | N | null | 280029826 | GEMCITABINE |
| 280005861 | 280003663 | 1.72 | 62 | Palliative (P) | 2017-10-26 | 2017-11-14 | OCTREOTIDE | 02 | N | 280029826 | VIDE |
| 280005862 | 280003664 | 1.75 | 71 | Curative (C) | 2017-03-26 | 2017-04-11 | Cisplatin + Etoposide (3 day) | N | N | 280029834 | RMS 2005 TRIAL |
| 280005863 | 280003665 | null | 107 | Curative (C) | 2015-05-22 | 2015-05-22 | GEMCITABINE | 2 | Y | 280029837 | COMPARE TRIAL |
| 280005864 | 280007971 | 1.79 | 70.6 | Curative (C) | 2013-06-12 | 2013-06-12 | Capecitabine | 02 | N | 280029838 | CHOP R |
| 280005865 | 280003666 | 1.75 | 118.5 | Curative (C) | 2014-12-11 | 2014-12-11 | PATHOS Trial | 02 | N | 280029839 | IRINOTECAN + VINCRISTINE |
| 280005866 | 280003666 | 1.66 | 86.4 | Adjuvant (A) | 2013-11-24 | 2013-11-28 | CHOP R - 21 days | N | N | 280029839 | GEMCARBO |
| 280005867 | 280003667 | 1.59 | null | null | 2013-08-29 | 2013-08-29 | Paclitaxel 7 day | N | N | 280029842 | LIPOSOMAL DOXORUBICIN |
| 280005868 | 280003667 | null | 108.65 | Curative (C) | 2018-02-18 | 2018-02-25 | Cisplatin + Fluorouracil + RT 5day | Y | N | 280029842 | IVA |
| 280005869 | 280003667 | -1 | null | Palliative (P) | 2012-11-04 | 2012-11-14 | PACLITAXEL | 02 | N | 280029842 | PACLITAXEL |
| 280005870 | 280003668 | 1.88 | 78.6 | Adjuvant (A) | 2014-09-21 | 2014-09-21 | TCF | N | N | 280029847 | DOCETAXEL |
| 280005871 | 280003668 | 1.62 | 58.6 | Palliative (P) | null | 2018-08-13 | CISPLATIN + TEYSUNO | 01 | null | 280029847 | LIPOSOMAL DOXORUBICIN |
| 280005872 | 280003668 | 1.7 | null | Neo-adjuvant (N) | 2016-12-14 | 2016-12-14 | LANREOTIDE | N | null | 280029847 | EURO-EWING |
| 280005873 | 280003668 | 1.77 | 0 | Palliative (P) | 2017-03-28 | 2017-03-29 | Cetuximab +Cisplatin + FU (Cycle 1) | N | N | 280029847 | CISPLATIN + DOXORUBICIN |
| 280005874 | 280003669 | 1.7 | 61.8 | Curative (C) | 2016-08-15 | 2016-08-21 | TCF | 2 | N | 280029854 | DE-ESCALATE TRIAL |
| 280005875 | 280003669 | 1.8 | 52 | null | 2017-06-11 | 2017-06-22 | CAPECITABINE + CARBOPLATIN | N | N | 280029854 | DE-ESCALATE TRIAL |
| 280005876 | 280003669 | null | 58.6 | null | 2016-11-15 | 2016-11-15 | DE-ESCALATE TRIAL | null | null | 280029854 | FLUOROURACIL + MITOMYCIN + RT |
| 280005877 | 280003669 | 0 | 119.2 | Curative (C) | 2013-10-13 | 2013-10-29 | Ifosfamide PVI 1g/m2 14day | 01 | null | 280029854 | IVA |
| 280005878 | 280003670 | 0 | 83.1 | Disease modification (D) | 2018-06-16 | 2018-06-27 | Capecitabine (21 day) + Irinotecan | 2 | null | 280029862 | PACLITAXEL |
| 280005879 | 280003671 | 1.67 | null | Palliative (P) | 2017-05-15 | 2017-05-23 | Paclitaxel 7 day | 99 | null | 280029866 | CISPLATIN + DOCETAXEL |